Greg Yap

Greg is a partner at Menlo Ventures, where he invests in teams trying to solve major problems in life science and healthcare, with a special interest in novel therapeutic platforms, patient-focused digital health, and transformative technologies. Since joining Menlo in 2017, Greg has led investments in Clear Labs, Delfi Diagnostics, Encoded Therapeutics, Epiodyne, Pliant Therapeutics, Senti Biosciences, and Vital Labs.